vip924
vincerx pharma
['lymphoma', 'vip924', 'biocon', 'vincerx']
we are excited to continue advancing our bioconjugation platform with our first-in-class antibody-drug conjugate, vip924. at #aacr23, we presented meaningful preclinical activity for vip924 in patient-derived lymphoma mouse models. read more here: 
A clinical-stage company focused on leveraging its extensive development and #oncology expertise to advance new therapies for the treatment of #cancer.